This study highlights EBV infection and frequencies of PD-1 positive T CD3+ cells (CD4+ and CD8+) and B cells (CD 19+) as risk factors in CLL patients. The gene discussed is PDCD1; the disease is B-cell chronic lymphocytic leukemia.